Apellis Pharmaceuticals, Inc. (APLS)

NASDAQ: APLS · Real-Time Price · USD

Compare

19.26

-0.45 (-2.28%)

At close: Nov 7, 2025, 4:00 PM EST

19.29

+0.03 (0.16%)

After-hours: Nov 7, 2025, 7:58 PM EST

Apellis Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	1,016	781.37	396.59	75.42	66.56	250.65	Upgrade
Revenue Growth (YoY)	42.11%	97.02%	425.83%	13.31%	-73.44%	-	Upgrade
Cost of Revenue	411.35	445.29	412.9	392.87	426.07	303.59	Upgrade
Gross Profit	605.05	336.07	-16.31	-317.45	-359.51	-52.94	Upgrade
Selling, General & Admin	524.64	501.05	500.82	277.16	176.77	139.4	Upgrade
Research & Development	-	-	-	-	-	21.38	Upgrade
Operating Expenses	524.64	501.05	500.82	277.16	176.77	160.78	Upgrade
Operating Income	80.41	-164.98	-517.12	-594.61	-536.28	-213.73	Upgrade
Interest Expense	-45.01	-40.39	-29.58	-32.63	-13.24	-29.94	Upgrade
Interest & Investment Income	13.04	12.77	20.93	8.91	0.42	4.16	Upgrade
Other Non Operating Income (Expenses)	-1.75	-2.17	-0.73	-0.29	-96.31	-103.53	Upgrade
EBT Excluding Unusual Items	46.68	-194.77	-526.5	-618.61	-645.41	-343.03	Upgrade
Other Unusual Items	-	-1.95	-	-32.89	-100.59	-	Upgrade
Pretax Income	46.68	-196.72	-526.5	-651.5	-746	-343.03	Upgrade
Income Tax Expense	1.7	1.16	2.13	0.67	0.35	1.85	Upgrade
Net Income	44.99	-197.88	-528.63	-652.17	-746.35	-344.87	Upgrade
Net Income to Common	44.99	-197.88	-528.63	-652.17	-746.35	-344.87	Upgrade
Shares Outstanding (Basic)	126	124	119	106	84	75	Upgrade
Shares Outstanding (Diluted)	128	124	119	106	84	75	Upgrade
Shares Change (YoY)	4.30%	4.40%	11.84%	25.70%	12.32%	20.79%	Upgrade
EPS (Basic)	0.36	-1.60	-4.45	-6.15	-8.84	-4.59	Upgrade
EPS (Diluted)	0.36	-1.60	-4.45	-6.15	-8.84	-4.59	Upgrade
Free Cash Flow	78.64	-88.27	-595.51	-515.27	-564.23	-165.91	Upgrade
Free Cash Flow Per Share	0.61	-0.71	-5.02	-4.86	-6.68	-2.21	Upgrade
Gross Margin	59.53%	43.01%	-4.11%	-	-	-21.12%	Upgrade
Operating Margin	7.91%	-21.11%	-130.39%	-788.38%	-805.67%	-85.27%	Upgrade
Profit Margin	4.43%	-25.32%	-133.29%	-864.70%	-1121.28%	-137.59%	Upgrade
Free Cash Flow Margin	7.74%	-11.30%	-150.16%	-683.18%	-847.66%	-66.19%	Upgrade
EBITDA	82.08	-163.18	-515.34	-593.06	-534.9	-213.09	Upgrade
EBITDA Margin	8.08%	-20.88%	-129.94%	-	-	-85.02%	Upgrade
D&A For EBITDA	1.68	1.8	1.78	1.55	1.38	0.64	Upgrade
EBIT	80.41	-164.98	-517.12	-594.61	-536.28	-213.73	Upgrade
EBIT Margin	7.91%	-21.11%	-130.39%	-	-	-85.27%	Upgrade
Revenue as Reported	1,016	781.37	396.59	75.42	66.56	250.65	Upgrade
Advertising Expenses	-	83.3	86.5	56.5	-	-	Upgrade

Updated Oct 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q